The nurse is reviewing the charts from a multicultural health clinic. The nurse needs to know that for three cultures, the listed first name is actually the family name, while the individual's given name is placed last
The three cultures with this variation are: 1. French, German, and Irish.
2. Cambodian, Filipino, and Korean.
3. Canadian, Egyptian, and Haitian.
4. Brazilian, English, and Jewish.
2
Rationale 1: In France, Germany, and Ireland, the family name is listed second.
Rationale 2: The listed first name is in fact the family name in Cambodian, Filipino, and Korean cultures.
Rationale 3: In Canada, Egypt, and Haiti, the family name is listed second.
Rationale 4: In Brazil and England, and in Jewish culture, the family name is listed second.
Global Rationale:
You might also like to view...
A patient takes a psychotropic medication that affects serotonin receptors. The patient complains of anxiety, insomnia, and loss of appetite. What effect is the drug having on the serotonin receptors?
a. Activation b. Antagonism c. Paradoxical d. Inhibition
Sacket noted that the practice of evidence-based practice means integrating individual clinical expertise with the best available external evidence from systematic research
A) True B) False
The nurse is taking care of a client who states that he ignores the urge to defecate when he is at work. Which response should the nurse make to explain why this practice should be changed?
1. "If you continue to ignore the urge to defecate, the urge is ultimately lost." 2. "It is best to suppress the urge rather than suffer embarrassment at work." 3. "This is a common practice, and it will strengthen the reflex later." 4. "You will get the urge later; don't worry."
The nurse is caring for a patient who begins to complain of shortness of breath. Upon further assessment, the nurse notes 3+ pitting edema bilaterally in the lower extremities
Which medication taken by the patient would most concern the nurse with regard to these findings? a. Epoetin alfa b. Oprelvekin (interleukin-11) c. Filgrastim (granulocyte colony–stimulating factor) d. Sargramostim (granulocyte-macrophage colony–stimulating factor